The biosynthesis of urea from ammonia and carbon dioxide requires five enzymes. One enzyme, carbamylphosphate synthetase converts ammonia and bicarbonate to carbamyl phosphate, which subsequently condenses with ornithine to form citrulline, a reaction catalysed by ornithine transcarbamylase. Citrulline is then converted by argininosuccinic acid synthetase to argininosuccinic acid, which is cleaved to form arginine and fumaric acid. The enzyme arginase finally converts arginine to ornithine and urea.
All of these enzymes, with the exception of arginase, have been associated with an inborn error of metabolism: hyperammonaemia with a defective ornithine transcarbamylase (Russell et al., 1962; Levin and Russell, 1967) , citrullinaemia with a defective argininosuccinate synthetase (McMurray et al., 1962) , and argininosuccinic aciduria with a defective argininosuccinic acid cleavage enzyme (Allen et al., 1958) .
Mental retardation is a common feature of these enzymatic defects, but it is uncertain whether the cerebral defect is due to accumulation of ammonia. There is increasing evidence that the urea cycle proceeds in the brain cells (Sporn et al., 1959; Kemp and Woodbury, 1965) , so that brain damage may be due to toxic effects of accumulated urea cycle intermediates and not necessarily to a high ammonia level.
Five cases with a high blood ammonia level (postprandial ammonaemia) due to enzymatic defects have been described. In 4 of these cases enzyme activity determinations have been carried out (Freeman et al., 1964; Russell et al., 1962; Levin and Russell, 1967 ). In the case described by Freeman et al. (1964) a reduced activity of carbamylphosphate synthetase with normal activities of the other enzymes of the urea cycle was found. The other 3 cases showed a very low activity of liver ornithine transcarbamylase, though the activity of carbamylphosphate synthetase was also below the normal value (see Addendum). Received April 21, 1969. A case is described of carbamylphosphate synthetase deficiency with normal ornithine transcarbamylase activity.
Case Report This child, born July 18, 1967 , was admitted to hospital at the age of 20 days, because she fed poorly, was lethargic, and had irregular eye movements and slight convulsions. She had been born after an uncomplicated pregnancy of 40 weeks. Birthweight 3250 g.
Two other children of this family had died with similar symptoms, both at the age of 4 weeks, a boy born in 1962 and a girl born in 1965. Necropsies of these sibs showed extensive cerebral spongy degeneration, especially of the brain-stem and basal nuclei. 2 other children of the same marriage are normal.
On admission the infant's weight was 3490 g. She was extremely lethargic. Tendon reflexes were decreased. Moro reflex was absent. Bilateral papilloedema was present. Liver and spleen were not enlarged. EEG on admission showed no epileptic activity or other gross abnormalities of the wave pattern.
At the age of 2 months, however, epileptic activity was noted in the EEG, and at an age of 7 months generalized paroxysmal high voltage complexes were present with maximum voltage occipital [±V) at a frequency of 2-4 per 10 sec.
Hb 19-4 g.f100 ml.; haematocrit 60%; erythrocytes 4 08 x 106/cu.mm.; leucocytes 6600/cu.mm.; thrombocytes 247,000/cu.mm.; reticulocytes 2%o. Serum electrolytes were within normal limits. Lactic dehydrogenase 400 U per ml.; SGOT and SGPT normal.
Serum protein 4 8 g./100 ml.; 46 7% albumin, 6.6% a,-globulin, 9*8% a,-globulin, 9*9% p,-globulin, 5.2% fl2-globulin, and 21.8% y-globulin. CSF: no cells, protein content normal, with a normal differentiation. Fasting blood glucose levels varied between 100 and 150 mg./100 ml.
A summary of medication and diet is given in Table I , along with blood pH values, and urea and ammonia concentrations in plasma. A slight metabolic alkalosis was present. Blood urea values were low at all times, even taking into account the relatively low protein intake. The infant did not gain weight, nor was she in positive nitrogen balance, a situation that normally leads to an increased blood urea concentration. The blood ammonia levels were in the upper range of normal (normal range: 20-60 y/100 ml.). This suggested a defect in the urea cycle, later confirmed by assay of the appropriate liver enzymes in liver tissue obtained by biopsy.
Shortly after admission a formula low in protein was prescribed, and at first there was an improvement in the general condition, but later she began to deteriorate, and she died aged 7j months.
At necropsy no gross abnormalities were found. Microscopical examination of the brain revealed spongy degeneration, especially in the brain-stem and basal nuclei, bilateral and symmetrical. These microscopical appearances were similar to those observed in the sibs who had died after a similar clinical course.
Methods
Amino acids were analysed by the photoelectric ninhydrin method of Moore and Stein (1954) with an automatic Spinco Beckman Amino Acid Analyzer.
Plasma and CSF were deproteinized with picric acid . Blood lactate and pyruvate were estimated enzymatically as described by Hohorst (1965) , and ammonia as described by Gips (1968) . Oxygen consumption was measured by the open method of Noyons, using a diaferometer (Kipp, Delft, The Netherlands). A test for maple syrup urine disease with leucocytes was carried out (Dancis, Hutzler, and Levitz, 1963) . The enzymes of the urea cycle were determined by the methods of Brown and Cohen (1959) , with minor modifications. Activities of enzymes of glycolysis of liver and brain were determined fluorimetrically using an Eppendorf fluorimeter as described by Estabrook and Maitra (1962) , by coupling to a nicotinamide adenine dinucleotide-dependent system in such a way that the enzyme to be tested was made rate-limiting (Bergmeyer, 1968 ). An aliquot of the homogenate was diluted to 3 ml. in a buffer containing 80 mM. triethanolamine, 20 mM KC1, 10 mM NaCl, and 5 mM MgCl,, pH 7*3. Enzymes, co-enzymes, and substrates were supplied by Boehringer and Soehne, Mannhein, Germany, and used without further purification. Liver biopsy material (about 10 mg.), obtained with a Menghini needle, was homogenized in ice-cold 0 25 M sucrose and 10 mM triethanolamine, pH 7 4. For the assay of urea cycle enzymes whole homogenates were used; for glycolytic enzymes the homogenates were centrifuged for 1 hour at 0 'C. at 20,000 r.p.m. and the supematant used. Post-mortem tissue was homogenized in the ice-cold 0 * 44 sucrose and 10 mM triethanolamine, pH 7 * 4.
Results
As the post-mortem examination of the brain of the patient's sibs had been thought to show some features of maple syrup urine disease, the patient's leucocytes were incubated with 1-14C-leucine to determine the rate of oxidative decarboxylation of the corresponding ketoacid, though the plasma amino acid levels (see below) were not indicative of this disease. After incubation for 1 hour at 37 'C. of leucocyte-enriched blood, a healthy control gave a production of 0 91 m,t moles of CO2, a value well in line with those published by Dancis, Hutzler, and Levitz (1960) . The same procedure with the patient's leucocyte-enriched blood gave 0 * 60 mlu moles of CO2. Since in maple syrup urine disease there is complete absence of CO2 production (Dancis et al., 1960 and , maple syrup urine disease should be excluded.
The plasma amino acid analysis (Table II) gave a normal pattern except for arginine which was significantly reduced. Our laboratory normal value for arginine for children of that age is 0 -10 ,umoles/ml., with a standard deviation of 0 02.
A similarly low arginine level was observed in CSF, 0 007 ,tmoles/ml. as compared to a normal value of 0 02 ,umoles/ml. Other amino acids in CSF, including glutamine, were within normal limits. This was to be expected, as blood ammonia levels were only in the upper range of normal.
The high initial blood glucose levels, combined with low blood pyruvate and lactate concentrations (1*3 and 3*0 mg./100 ml., respectively) and a moderately low over-all oxygen consumption (5 ml./kg. per min.) suggested a low capacity for glycolysis. Liver tissue, obtained by biopsy, gave a low activity of hexokinase and glucokinase (Table III , column 1) and an abnormal ratio of the two enzymes (with a normal diet the expected ratio is 4, Walker, Khan, and Eaton, 1966) . The glucokinase activity was low, having regard to the carbohydrate-rich diet of the patient at this time (c.f. Walker et al. 1966) . A second line of evidence for a disturbed carbohydrate metabolism came from the leucine tolerance curve (Fig.) . Only a moderate (Floyd et al., 1966) , when there was no significant decrease in blood glucose (Fig.) . She was therefore treated with insulin to stimulate glucokinase synthesis. A subsequent liver biopsy (Table III , column 2) revealed a doubling of the glucose phosphorylating enzymes. The plasma urea levels were low at all times, while normal plasma ammonia levels were observed, the protein intake being 1 .5 g./kg. at the time of measurement (Table I ). Even at a protein intake of 2 g./kg., the blood urea remained low (Table I , age 126 days). Similar low levels of urea were found in CSF. This suggested a defect in the urea cycle: as no excretion of citrulline or argininosuccinic acid could be detected, a defect in the urea cycle in the synthesis or utilization of carbamylphosphate was likely. The activity of carbamylphosphate synthetase was found to be low in liver biopsy tissue (Table IV) , and later also in postmortem liver tissue (0 * 28 and 0 * 24, normal value 0 * 67). Even more characteristic was the ratio of the ornithine transcarbamylase activity to the carbamylphosphate synthetase activity, which was found to be 43 in the liver biopsy. Russell et al. (1962) , and Levin and Russell (1967) report a value of about 10 for this ratio in human liver, which agrees well with our own normal values (Table IV) .
The activity of ornithine transcarbamylase was found to be normal, as was that of the other 3 enzymes of the urea cycle (Table IV) . The activity of carbamylphosphate synthetase as found here is lower than that found by other workers (0-6 ,umole/min. per g. wet weight, as compared with 3-0 ,umole/min. per g. wet weight ; Russell et al., 1962; Raiha and Suihkonen, 1968) . The same holds true for ornithine transcarbamylase (12-0, as compared with 40 ,umole/min. per g. wet weight). These differences may be methodological. A high ratio of ornithine transcarbamylase activity to carbamylphosphate synthetase activity was observed also in a post-mortem brain biopsy. This may indicate that the enzyme carbamylphosphate synthetase was deficient in brain as well as in liver tissue, though suitable control values were lacking. Discussion Raiha and Suihkonen (1968) have shown that the development of carbamylphosphate synthetase in human liver is completed at birth, so that the low activity of this enzyme in our patient was certainly abnormal. It should be mentioned that pyridine nucleotide biosynthesis is not disturbed by this deficiency, as a cytoplasmic carbamylphosphate synthetase with glutamine as nitrogen donor is responsible for this metabolic route (Jones and Hager, 1966) . How far the moderately decreased level of enzyme activity as found in several organs, i.e. liver and brain, relates to the extensive brain damage, remains a question. This low activity of carbamylphosphate synthetase results in reduced activity of the urea cycle, and the low blood urea levels found in our patient. Blood arginine level will also be low (Table II) glucokinase (Sharma, Manjeskwan, and Weinhouse, 1963; Sols, Sillero, and Salas, 1965) . A moderately high blood glucose level and low blood pyruvate and lactate levels are suggestive of a low rate of glycolysis. In the first liver biopsy a low glucokinase activity was indeed found (Table III) . In the second biopsy, done after insulin administration, the glucokinase activity had increased. It was observed that no additional insulin was secreted after stimulation by leucine (Fig.) . (A normal response should increase the plasma insulin level by about 25 ,uU/ml. (Floyd et al., 1966).) This suggested that the insulin secreting mechanism failed to respond to amino acid activation. Insulin was therefore administered, and after this course of insulin treatment was terminated the system reacted normally, as can be seen from the postmortem liver enzyme determination (Table III,  column 3 ). This suggests that a decreased activity of the urea cycle, due to a specific enzyme deficiency, may lead to disturbances in carbohydrate metabolism.
Though the patient initially improved on a low protein diet and blood ammonia levels were never excessively high, the diet failed to prevent extensive brain damage leading to death. The high ratio of ornithine transcarbamylase to carbamylphosphate synthetase activities observed in the brain (Table IV) suggests that the enzyme was missing not only in the liver, where the bulk of urea production takes place, but also in the brain. The role of the urea cycle in the brain has not yet been studied extensively (Kemp and Woodbury, 1965) . Further animal experiments will be needed to investigate whether an impaired brain urea cycle can lead to extensive brain damage as observed in our cases.
Despite the decreased carbamylphosphate synthetase activity, the blood ammonia level was normal. This is in contrast to the patients described by Russell et al. (1962) and by Levin and Russell (1967) who had a reduced carbamylphosphate synthetase activity, together with a much more reduced activity of ornithine transcarbamylase. The normal blood ammonia level may have been the result of the low protein intake which was probably responsible for prolonging our patient's life, for her untreated brother and sister lived only 4 weeks.
The familial pattern incidence of our cases is in keeping with carbamylphosphate synthetase deficiency being inherited as a recessive autosomal. Summary A case is described of an infant with a deficiency of carbamylphosphate synthetase in liver and brain.
The child died at the age of 71 months. Postmortem examination showed extensive brain damage, particularly in the brain-stem and basal nuclei. Low activity of the urea cycle, due to carbamylphosphate synthetase deficiency, was shown to affect carbohydrate metabolism via decreased insulin secretion and inhibited glucokinase induction.
The parents were unrelated. Of their four other children, two were normal, and two had died at the age of 4 weeks with identical symptoms. The family history suggests that carbamylphosphate synthetase deficiency is an inborn error of metabolism with a recessive inheritance.
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